Phospholemman
WebOct 27, 2006 · Phospholemman (PLM) or FXYD1 is a major cardiac myocyte phosphorylation target upon adrenergic stimulation. Prior immunoprecipitation and functional studies suggest that phospholemman associates with the Na/K-pump (NKA) and mediates adrenergic Na/K-pump regulation. WebJan 1, 2005 · Phospholemman (PLM) is a 72-amino acid transmembrane protein thought to function in Na,K-ATPase regulation or assembly, similar to other members of the FXYD family of proteins.
Phospholemman
Did you know?
WebPhospholemman-mediated activation of Na/K-ATPase limits [Na]i and inotropic state during β-adrenergic stimulation in mouse ventricular myocytes — University of Kentucky Phospholemman-mediated activation of Na/K-ATPase limits [Na]i and inotropic state during β-adrenergic stimulation in mouse ventricular myocytes WebPhospholemman Antibodies. Santa Cruz Biotechnology, Inc. offers a broad range of Phospholemman antibodies. Select Phospholemman antibodies from monoclonal …
WebDec 18, 2024 · In aging wild-type mice, phospholemman was hypophosphorylated, and this correlated with the development of aging-induced essential hypertension. In humans, we … WebJan 1, 2024 · Phospholemman (PLM) is a 72-amino-acid type I single-span membrane protein, belonging to the FXYD (pronounced “fix-it”) family of ion transport regulators. These smallmembrane proteins are tissue-specific regulators of the Na/K ATPase (Na/K pump or …
WebJan 15, 2016 · Our work has focused mainly -ATPase(FXYD2), CorticosteroidHormone nducedFactor (CHI FXYD4),which basolateralmembrane differentkidney cells, colon(CHI homeostasis.More recently we turned our attention FXYD1(phospholemman, PLM), which regulates skeletalmuscle. PLM has PKA PKCphosphorylation sites otherhormonal signals. WebThe FXYD protein family is a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the amino acid sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator.
WebDec 11, 2012 · In heart, phospholemman (PLM) inhibits NKA activity by reducing its apparent Na (+) affinity, an effect that is relieved by PLM phosphorylation. The NKA crystal structure suggests regions of PLM-NKA interaction, but the sites important for functional effects in live cells are not known.
WebLijst met PDB-id-codes; 2MKV. ID's; Aliassen: FXYD2, ATP1G1, HOMG2, FXYD-domein met ionentransportregulator 2: Externe ID's: OMIM: 601814 HomoloGene: 86992 GeneCards ... csulb speech clinicWebJan 1, 2016 · Phospholemman (PLM) is a regulatory subunit of the cardiac Na+/K+-ATPase (NKA), but exists also as an independent tetramer. The membrane-spanning protein consists of 72-amino acid residues and is... csulb sports psychologyWebBackground: Phospholemman regulates the plasmalemmal sodium pump in excitable tissues. … csulb spanish majorWebMar 1, 2024 · Phospholemman (PLM, also known as FXYD1) is a 72 amino acid transmembrane muscle cell protein 13–15 which forms a stable complex with NKA. 16, 17 The cytosolic C-terminus of PLM bears at least three different phosphorylation sites, one of them Ser68 can be phosphorylated by PKA and protein kinase C. 18–20 PLM tonically … csulb sportsWebDec 18, 2024 · The study carried out by Boguslavskyi et al. illustrated that phospholemman is hypophosphorylated in a mouse model of aging that induces senescent essential hypertension. Phosphorylation of... csulb speech pathology programWebPhospholemman (PLM) is a member of the FXYD ('fix-it') family of proteins many of which have now been identified as tissue-specific regulators of the Na/K ATPase. PLM (FXYD1) is the primary sarcolemmal substrate for PKC and PKA in the heart. We have recently identified PLM as a novel accessory prote … csulb spanish departmentWebA decrease in the skeletal muscle Na,K-ATPase (NKA) activity contributes to pathogenesis of diabetes mellitus complications. Restoration of sodium pump activity in skeletal muscle may be an important goal for the treatment of metabolic disorders its complications.The NKA partner protein phospholemman (PLM), a major sarcolemmal substrate for protein … csulb sports management masters